Amussen Hunsaker Associates LLC Boston Scientific Corp Transaction History

Amussen Hunsaker Associates LLC

  • $715 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 19, 2019
SELL
$31.73 - $39.04 $187,619 - $230,843
-5,913 Closed
0 $0
Q3 2018

Nov 16, 2018
BUY
$32.83 - $38.63 $97,373 - $114,576
2,966 Added 100.64%
5,913 $214,000
Q2 2018

Aug 16, 2018
BUY
$26.84 - $34.32 $79,097 - $101,141
2,947 New
2,947 $96,000

Others Institutions Holding BSX

# of Institutions
1,542
Shares Held
1.19B
Call Options Held
6.79M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $128B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Amussen Hunsaker Associates LLC Portfolio

Follow Amussen Hunsaker Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amussen Hunsaker Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Amussen Hunsaker Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email